MX388528B - Vacuna que comprende toxoides de clostridium. - Google Patents

Vacuna que comprende toxoides de clostridium.

Info

Publication number
MX388528B
MX388528B MX2019013779A MX2019013779A MX388528B MX 388528 B MX388528 B MX 388528B MX 2019013779 A MX2019013779 A MX 2019013779A MX 2019013779 A MX2019013779 A MX 2019013779A MX 388528 B MX388528 B MX 388528B
Authority
MX
Mexico
Prior art keywords
difficile
toxoid
toxoids
clostridium
vaccine
Prior art date
Application number
MX2019013779A
Other languages
English (en)
Spanish (es)
Other versions
MX2019013779A (es
Inventor
Arnau Marta Sitjà
Pérez Xavier Gibert
Original Assignee
Hipra Scient S L U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hipra Scient S L U filed Critical Hipra Scient S L U
Publication of MX2019013779A publication Critical patent/MX2019013779A/es
Publication of MX388528B publication Critical patent/MX388528B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2019013779A 2017-06-09 2018-06-07 Vacuna que comprende toxoides de clostridium. MX388528B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382358 2017-06-09
PCT/EP2018/065025 WO2018224595A1 (en) 2017-06-09 2018-06-07 Vaccine comprising clostridium toxoids

Publications (2)

Publication Number Publication Date
MX2019013779A MX2019013779A (es) 2020-01-13
MX388528B true MX388528B (es) 2025-03-20

Family

ID=59078007

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019013779A MX388528B (es) 2017-06-09 2018-06-07 Vacuna que comprende toxoides de clostridium.

Country Status (8)

Country Link
US (1) US11154605B2 (enExample)
EP (1) EP3634480A1 (enExample)
JP (2) JP7349366B2 (enExample)
BR (1) BR112019024412A2 (enExample)
CA (1) CA3064357A1 (enExample)
MX (1) MX388528B (enExample)
WO (1) WO2018224595A1 (enExample)
ZA (1) ZA201907715B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202509058A (zh) * 2023-08-24 2025-03-01 法商西華動物藥品股份有限公司 抗豬感染之多價疫苗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY149604A (en) 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
AR089797A1 (es) 2012-01-27 2014-09-17 Merck Sharp & Dohme Vacunas contra clostridum difficile que comprenden toxinas recombinantes
US20160045586A1 (en) 2013-03-15 2016-02-18 Sanofi Pasteur, Inc. Toxoid, Compositions and Related Methods

Also Published As

Publication number Publication date
ZA201907715B (en) 2024-09-25
WO2018224595A1 (en) 2018-12-13
CA3064357A1 (en) 2018-12-13
JP2020522471A (ja) 2020-07-30
MX2019013779A (es) 2020-01-13
US20200188500A1 (en) 2020-06-18
JP7349366B2 (ja) 2023-09-22
US11154605B2 (en) 2021-10-26
EP3634480A1 (en) 2020-04-15
JP2023113631A (ja) 2023-08-16
BR112019024412A2 (pt) 2020-07-14

Similar Documents

Publication Publication Date Title
CL2019003805A1 (es) Composiciones inmunógenas de senecavirus a y métodos de éstas.
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
MX395525B (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
BR112017023161A2 (pt) composições de ácido obeticólico e métodos de uso
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
MX2019008564A (es) Composiciones inmunogenicas para su uso en vacunas neumococicas.
PH12017502233A1 (en) Formulations for neoplasia vaccines and methods of preparing thereof
TNSN07387A1 (en) C.perfringens alpha toxoid vaccine
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
PE20151588A1 (es) Vacuna contra el virus del dengue
EA201991041A1 (ru) Вакцина против свиного парвовируса и вируса свиного репродуктивного и респираторного синдрома и способы ее получения
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
BR112018075440A2 (pt) composições e métodos para prevenir e tratar a infecção por zika vírus
BR112017003462A2 (pt) coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino.
MX381211B (es) Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia.
EA201990010A1 (ru) Вакцина против вируса инфекционного бронхита
BR112018010679A2 (pt) métodos para tratar, prevenir e diagnosticar a infecção por vírus da diarréia epidêmica porcina
GB2539148A (en) Vaccine compositions
BR112019003992A2 (pt) vacina contra neisseria meningitidis
CO2017007057A2 (es) Vacuna contra la fiebre aftosa
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
BR112015021523A8 (pt) composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
EA201792593A1 (ru) Пестивирусные вакцины против врожденного тремора
BR112018074910A2 (pt) composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito
MX2017013879A (es) Composiciones que comprenden anakinra.